COVID-19 convalescent plasma donor characteristics, product disposition, and comparison with standard apheresis donors.

Lasky, Baia; Goodhue Meyer, Erin; Steele, Whitney R; Crowder, Lauren A; Young, Pampee P

Lasky, Baia; Goodhue Meyer, Erin; Steele, Whitney R; Crowder, Lauren A; Young, Pampee P.

Affiliation

Lasky B; American Red Cross, Biomedical Services Headquarters, Washington, DC, USA.
Goodhue Meyer E; American Red Cross, Biomedical Services Headquarters, Washington, DC, USA.
Steele WR; Nationwide Children's Hospital, Columbus, Ohio, USA.
Crowder LA; American Red Cross, Biomedical Services Headquarters, Washington, DC, USA.
Young PP; American Red Cross, Biomedical Services Headquarters, Washington, DC, USA.

Transfusion ; 61(5): 1471-1478, 2021 05.

Article in En | MEDLINE | ID: mdl-33458811

Subject(s)

Blood Component Removal; Blood Donors; COVID-19/blood; COVID-19/therapy; Convalescence; SARS-CoV-2/metabolism; Adolescent; Adult; Aged; Aged, 80 and over; Female; Humans; Immunization, Passive; Male; Middle Aged; COVID-19 Serotherapy

Key words

COVID-19 convalescent plasma; donor demographics

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Component Removal / Blood Donors / Convalescence / SARS-CoV-2 / COVID-19 Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Transfusion Year: 2021 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google